GMR Solutions Inc
GMRSHealthcare·Medical Care Facilities·USA·Small·NYSE·Nov 12 • 3:59 PM ET
11.30-0.46 (-3.91%)
2026-11-13 01:00 CET
Market cap
$610.45M
Revenue, TTM
1,595.56 USD m
Net income, TTM
135.56 USD m
Free cash flow, TTM
110.29 USD m
EPS diluted, TTM
2.03
Price
GMRS against its 20 and 50-day averagesPatternshover a marker to name it
Sales mean, own scale
29.3% under the 52-week high of 15.98 on 13 Jul 2026. 52-week low 9.00 on 1 Oct 2026. Last 15 sessions, 27.8% high to low
Volume 1.42× normal · the line is the 50-bar volume average
Setup. RS line 22
CANSLIM 3 of 6 — fails: 52-Week High/Low: 0-10% below High — not on the tape: EPS Growth This Year: High (>25%); Performance: Year +50%
VCP 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Relative Volume: Under 1 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200
Minervini 0 of 4 — fails: 52-Week High/Low: 0-10% below High — not on the tape: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; Performance: Year +50%
Zanger 1 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5 — not on the tape: 200-Day Simple Moving Average: Price above SMA200
Leaders 2 of 5 — fails: 52-Week High/Low: 0-10% below High — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2 — not on the tape: 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Debt/Equity: Low (<0.1) — not on the tape: Return on Equity: Over +15%; Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15; Return on Equity: Over +15%
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 2 of 4 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — not on the tape: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
GMRS52-week range, 33% of the way up
9.0015.98
GMR Solutions, Inc. is a holding company, which engages in the provision of emergency medical services through its subsidiaries. The company is headquartered in Lewisville, TX.
| Index | RUT |
|---|---|
| Employees | 33858 |
| IPO | May 13, 2026 |
| ATR, 14d | 0.83 |
| Rel volume | 1.42 |
| Short float | 13.38% |
| Insider own | 34.70% |
| Inst own | 88.29% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $610.45M |
| Enterprise Value | 4.83B |
| Income | - |
| Sales | - |
| Book / share | 13.62 |
| Cash / share | 7.10 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 33858 |
| IPO | May 13, 2026 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | - |
| Price / book | 0.83 |
| Price / cash | 1.59 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | - |
| Quick Ratio | 1.63 |
| Current Ratio | 1.74 |
| Debt / equity | 5.07 |
| Long-term debt / equity | 4.80 |
| Options and short | No / Yes |
Earnings
| Earnings / share | - |
|---|---|
| Earnings next year | - |
| Earnings next quarter | 0.20 |
| Earnings this year | - |
| Earnings next year | - |
| Earnings growth, 5 years | - |
| Past earnings growth | - - |
| Past sales growth | 3.15% - |
| Earnings vs last year | - |
| Sales vs last year | - |
| Earnings vs last quarter | 35.95% |
| Sales vs last quarter | 10.65% |
| Earnings | Nov 09 AMC |
| Surprise | 27.08% 0.44% |
Ownership
| Insiders own | 34.70% |
|---|---|
| Insider trades | -11.15% |
| Institutions own | 88.29% |
| Institution trades | 41.74% |
| Return on assets | - |
| Return on equity | - |
| Return on capital | - |
| Gross Margin | - |
| Operating margin | - |
| Profit Margin | - |
| 20-day average | 1.56% |
| 50-day average | 0.24% |
| 200-day average | -8.41% |
Technical
| Shares out | 66.70M |
|---|---|
| Shares floating | 35.28M |
| Short / float | 13.38% |
| Short ratio | 4.52 |
| Short interest | 4.72M |
| 52-week high | 15.98 -29.3% |
| 52-week low | 9.00 +25.6% |
| Volatility | 11.38% 6.57% |
| Average range | 0.83 |
| Strength index | 50.43 |
| Market sensitivity | - |
| Relative volume | 1.42 |
| Avg Volume | 1.04M |
| Volume | 1,484,673 |
Performance
| Perf Week | -9.67% |
|---|---|
| Perf Month | 5.41% |
| Perf Quarter | -15.10% |
| Perf Half Y | -18.41% |
| Perf YTD | -16.30% |
| Perf Year | - |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recommendation | 1.38 |
| Target Price | 18.38 |
| Prev Close | 11.76 |
| Price | 11.30 |
| Change % | -3.91% |
Analyst ratings
latest 8 of 8| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Jun 08, 2026 | Initiated | UBS | Buy | $20 | +77.0% |
| Jun 08, 2026 | Initiated | Morgan Stanley | Equal-Weight | $14 | +23.9% |
| Jun 08, 2026 | Initiated | JP Morgan | Overweight | $15 | +32.7% |
| Jun 08, 2026 | Initiated | Goldman | Buy | $35 | +209.7% |
| Jun 08, 2026 | Initiated | Evercore ISI | Outperform | $20 | +77.0% |
| Jun 08, 2026 | Initiated | Citigroup | Buy | $17 | +50.4% |
| Jun 08, 2026 | Initiated | BofA Securities | Buy | $18 | +59.3% |
| Jun 08, 2026 | Initiated | Barclays | Overweight | $16 | +41.6% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| SRTA | Strata Critical Medical Inc | 515.37M |
| DCGO | DocGo Inc | 22.28M |
| MD | Pediatrix Medical Group Inc | 2.45B |
| CYH | Community Health Systems Inc | 311.67M |
| HCA | HCA Healthcare Inc | 104.58B |
| AMN | AMN Healthcare Services Inc | 1.44B |
| ARDT | Ardent Health Inc | 2.49B |
| THC | Tenet Healthcare Corp | 22.83B |
| UHS | Universal Health Services Inc | 11.17B |
| ASTH | Astrana Health Inc | 1.58B |
Insider trading
14 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Van Horne Edward | President & COO | Sep 14 '26 | Sale | 12.20 | 262,278 | 3,199,792 | 575,004 | Sep 15 06:06 AM |
| Tierney Brian Scott | EVP & CFO | Sep 14 '26 | Option Exercise | 7.20 | 42,500 | 306,000 | 851,470 | Sep 15 06:05 AM |
| Tierney Brian Scott | EVP & CFO | Sep 14 '26 | Sale | 12.20 | 265,794 | 3,242,687 | 554,955 | Sep 15 06:05 AM |
| Loporcaro Nicola | Chairman & CEO | Sep 14 '26 | Sale | 12.20 | 1,457,102 | 17,776,644 | 2,855,580 | Sep 15 06:04 AM |
| Jacoba Lisa | EVP & CHRO | Sep 14 '26 | Sale | 12.20 | 92,680 | 1,130,696 | 198,603 | Sep 15 06:02 AM |
| Hall Jessica | Chief Accounting Officer | Sep 14 '26 | Sale | 12.20 | 23,687 | 288,981 | 62,566 | Sep 15 06:01 AM |
| COOK THOMAS A A | EVP, GC & Secretary | Sep 14 '26 | Sale | 12.20 | 251,882 | 3,072,960 | 675,686 | Sep 15 06:00 AM |
| Brian Scott Tierney | Officer | Sep 14 '26 | Proposed Sale | 13.26 | 265,794 | 3,524,428 | Sep 14 09:12 PM | |
| Thomas A A Cook | Officer | Sep 14 '26 | Proposed Sale | 13.26 | 251,882 | 3,339,955 | Sep 14 09:11 PM | |
| Edward Van Horne | Officer | Sep 14 '26 | Proposed Sale | 13.26 | 262,278 | 3,477,806 | Sep 14 09:10 PM | |
| Nicola Loporcaro | Director & Officer | Sep 14 '26 | Proposed Sale | 13.26 | 1,457,102 | 19,321,173 | Sep 14 09:09 PM | |
| Lisa Jacoba | Officer | Sep 14 '26 | Proposed Sale | 13.26 | 92,680 | 1,228,937 | Sep 14 09:08 PM | |
| Jessica Hall | Officer | Sep 14 '26 | Proposed Sale | 13.26 | 23,687 | 314,090 | Sep 14 09:06 PM | |
| Jacoba Lisa | EVP & CHRO | May 14 '26 | Buy | 15.00 | 1,000 | 15,000 | 291,283 | May 15 04:37 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| MIGO | MIG Core ETF | AUM: 727.08M |
| CALF | Pacer US Small Cap Cash Cows ETF | AUM: 3.89B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| IWN | iShares Russell 2000 Value ETF | AUM: 14.17B |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-09 | 0.640 | 0.504 | 0.560 | 1,596 | 1,589 | 8 |
| 2026Q2 | 2026-08-12 | -1.840 | 0.265 | -0.524 | 1,490 | 1,472 | 8 |
| 2026Q1 | 2026-06-01 | 0.573 | - | 0.477 | 1,458 | - | - |
| 2026Q4 | - | - | 0.204 | - | - | 1,475 | 8 |
| 2027Q1 | - | - | 0.414 | - | - | 1,528 | 5 |
| 2027Q2 | - | - | 0.493 | - | - | 1,581 | 5 |
| 2027Q3 | - | - | 0.699 | - | - | 1,712 | 4 |
| 2027Q4 | - | - | 0.299 | - | - | - | 2 |
| 2028Q1 | - | - | 0.422 | - | - | 1,620 | 1 |
| 2028Q2 | - | - | 0.561 | - | - | 1,641 | 1 |
| 2028Q3 | - | - | 0.690 | - | - | 1,805 | 1 |
| 2028Q4 | - | - | 0.410 | - | - | 1,675 | 1 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-10 | 6 | 0 | 3 | 1,475 | 1,432 | 1,510 |
| 2026Q4 | S | 2026-09-10 | 6 | 0 | 0 | 1,498 | 1,480 | 1,510 |
| 2026Q4 | S | 2026-08-17 | 6 | 0 | 0 | 1,496 | 1,480 | 1,503 |
| 2026Q4 | S | 2026-08-14 | 6 | 0 | 0 | 1,496 | 1,480 | 1,503 |
| 2026Q4 | S | 2026-08-13 | 6 | 0 | 0 | 1,496 | 1,480 | 1,503 |
| 2026Q4 | S | 2026-06-08 | 6 | 0 | 0 | 1,497 | 1,480 | 1,501 |
| 2026Q4 | S | 2026-06-05 | 4 | 0 | 0 | 1,500 | 1,498 | 1,501 |
| 2026Q4 | S | 2026-06-04 | 1 | 0 | 0 | 1,501 | 1,501 | 1,501 |
| 2026Q4 | R | 2026-11-10 | 3 | 0 | 3 | 0.15 | 0.12 | 0.20 |
| 2026Q4 | R | 2026-10-27 | 3 | 0 | 1 | 0.16 | 0.13 | 0.20 |
| 2026Q4 | R | 2026-09-10 | 3 | 1 | 2 | 0.16 | 0.13 | 0.20 |
| 2026Q4 | R | 2026-08-13 | 3 | 2 | 1 | 0.17 | 0.15 | 0.20 |
| 2026Q4 | R | 2026-08-07 | 3 | 1 | 0 | 0.17 | 0.16 | 0.19 |
| 2026Q4 | R | 2026-06-08 | 3 | 0 | 0 | 0.17 | 0.15 | 0.19 |
Estimate history
| EPS, annual | -0.908 | -0.316 | 0.16 | |||
|---|---|---|---|---|---|---|
| Period | 2023 | 2024 | 2025 | |||
| EPS, quarterly | 0.17 | 1.495 | 0.453 | 0.477 | -0.524 | 2.032 |
| Period | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
| Sales, annual | 5394.711 | 5976.198 | 5739.776 | |||
| Period | 2023 | 2024 | 2025 | |||
| Sales, quarterly | 1367.407 | 1442.011 | 1506.868 | 1457.576 | 1490.286 | 1595.555 |
| Period | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
| Shares, annual | 223.145 | 223.145 | 223.145 | 66.698 | ||
| Period | 2023 | 2024 | 2025 | MRQ | ||
| Shares, quarterly | 223.145 | 54.022 | 21.814 | 223.145 | 54.022 | 66.698 |
| Period | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Total Revenue | 1,595.56 | 5,739.78 | 5,976.20 | 5,394.71 |
| Cost of Goods Sold Incl. D&A | 1,030.28 | 3,836.66 | 3,835.28 | 3,630.55 |
| Gross Profit | 565.28 | 1,903.11 | 2,140.92 | 1,764.16 |
| Selling, General and Administrative Excl. Other | 293.58 | 1,079.00 | 1,419.40 | 1,343.06 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 271.70 | 824.12 | 721.52 | 421.11 |
| Interest Expense | 68.06 | 422.67 | 499.25 | 521.16 |
| Unusual Expense | 10.23 | 78.27 | 122.83 | 70.53 |
| Net Income Before Taxes | 194.46 | 316.53 | 114.52 | -160.59 |
| Income Taxes | 58.91 | 110.30 | 94.11 | 42.07 |
| Consolidated Net Income | 135.56 | 206.23 | 20.41 | -202.66 |
| Net Income From Continuing Operations | 135.56 | 206.23 | 20.41 | -202.66 |
| Net Income | 135.56 | 35.76 | -70.41 | -202.66 |
| EPS (Recurring) | 2.14 | 0.41 | 0.07 | -0.69 |
| EPS (Basic, Before Extraordinaries) | 2.03 | 0.16 | -0.32 | -0.91 |
| EPS (Diluted) | 2.03 | 0.16 | -0.32 | -0.91 |
| EBITDA | 350.23 | 1,153.71 | 1,019.32 | 735.55 |
| Non-Operating Income (Expense) | 1.05 | -6.66 | 15.09 | 10.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.23 | 9.34 | 43.44 | 4.87 |
| Gross Margin | - | 33.16 | 35.82 | 32.70 |
| Operating Margin | - | 14.36 | 12.07 | 7.81 |
| Net Margin | - | 0.62 | -1.18 | -3.76 |
| Shares Outstanding | 66.70 | 223.15 | 223.15 | 223.15 |
| Market Capitalization | 635.30 | 635.30 | - | - |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Total Revenue | 1,595.56 | 1,490.29 | 1,457.58 | 1,506.87 | 1,442.01 | 1,367.41 |
| Cost of Goods Sold Incl. D&A | 1,030.28 | 1,137.89 | 963.99 | 966.95 | 927.74 | 921.70 |
| Gross Profit | 565.28 | 352.39 | 493.58 | 539.92 | 514.27 | 445.71 |
| Selling, General and Administrative Excl. Other | 293.58 | 282.78 | 271.07 | 282.37 | 272.21 | 249.46 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 271.70 | 69.61 | 222.51 | 257.55 | 242.06 | 196.25 |
| Interest Expense | 68.06 | 76.85 | 83.17 | 107.20 | 108.52 | 113.69 |
| Unusual Expense | 10.23 | 12.93 | 3.61 | 46.72 | 1.05 | 18.40 |
| Net Income Before Taxes | 194.46 | -19.30 | 142.53 | 104.48 | 122.29 | 67.39 |
| Income Taxes | 58.91 | 8.98 | 36.20 | 29.89 | 41.53 | 29.37 |
| Consolidated Net Income | 135.56 | -28.28 | 106.34 | 74.60 | 80.76 | 38.02 |
| Net Income From Continuing Operations | 135.56 | -28.28 | 106.34 | 74.60 | 80.76 | 38.02 |
| Net Income | 135.56 | -28.28 | 106.34 | 9.89 | 80.76 | 38.02 |
| EPS (Recurring) | 2.14 | -0.36 | 0.49 | 1.95 | 1.51 | 0.23 |
| EPS (Basic, Before Extraordinaries) | 2.03 | -0.52 | 0.48 | 0.45 | 1.50 | 0.17 |
| EPS (Diluted) | 2.03 | -0.52 | 0.48 | 0.45 | 1.50 | 0.17 |
| EBITDA | 350.23 | 146.57 | 297.88 | 330.92 | 314.57 | 271.38 |
| Non-Operating Income (Expense) | 1.05 | 0.86 | 6.81 | 0.86 | -10.20 | 3.22 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.23 | 104.76 | 0.07 | 4.55 | 2.36 | 2.06 |
| Gross Margin | 35.43 | 23.65 | 33.86 | 35.83 | 35.66 | 32.60 |
| Operating Margin | 17.03 | 4.67 | 15.27 | 17.09 | 16.79 | 14.35 |
| Net Margin | 8.50 | -1.90 | 7.30 | 0.66 | 5.60 | 2.78 |
| Shares Outstanding | 66.70 | 54.02 | 223.15 | 21.81 | 54.02 | 223.15 |
| Market Capitalization | 635.30 | 835.02 | 795.05 | - | - | - |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY |
|---|---|---|---|
| Cash & Short Term Investments | 687.96 | 434.81 | - |
| Short Term Receivables | 1,094.81 | 1,077.82 | - |
| Inventories | 115.72 | 105.70 | - |
| Other Current Assets | 233.59 | 199.21 | - |
| Total Current Assets | 2,132.08 | 1,817.54 | - |
| Net Property, Plant & Equipment | 1,649.57 | 1,523.22 | - |
| Total Investments and Advances | 1.90 | 1.50 | - |
| Intangible Assets | 3,384.82 | 3,489.10 | - |
| Deferred Tax Assets | 416.25 | 391.51 | - |
| Other Assets | 313.68 | 285.25 | - |
| Total Assets | 7,898.29 | 7,508.11 | - |
| Short Term Debt Incl. Current Port. of LT Debt | 225.86 | 235.41 | - |
| Accounts Payable | 60.05 | 54.66 | - |
| Other Current Liabilities | 778.52 | 725.36 | - |
| Total Current Liabilities | 1,064.43 | 1,015.43 | - |
| Long Term Debt | 5,145.59 | 4,624.95 | - |
| Provision for Risks Charges | 312.07 | 251.09 | - |
| Deferred Tax Liabilities | 625.31 | 561.48 | - |
| Other Liabilities | 101.59 | 89.78 | - |
| Total Liabilities | 7,249.00 | 6,542.73 | - |
| Non-Equity Reserves | 0.00 | 0.00 | - |
| Preferred Stock - Carrying Value | 445.14 | 777.39 | - |
| Common Equity | 204.16 | 188.00 | - |
| Total Shareholders Equity | 649.29 | 965.38 | - |
| Accumulated Minority Interest | 0.00 | 0.00 | - |
| Total Equity | 649.29 | 965.38 | - |
| Total Liabilities & Stockholders Equity | 7,898.29 | 7,508.11 | - |
| Book Value Per Share | 0.91 | 0.84 | - |
| Tangible Book Value Per Share | -14.25 | -14.79 | - |
| Full-Time Employees | 33,858 | - | - |
| Price to Book Ratio | 0.86 | - | - |
| Return on Assets | 2.68 | - | - |
| Return on Equity | 25.54 | - | - |
| Return on Invested Capital | 3.56 | 0.37 | - |
| Quick Ratio | 1.89 | 1.69 | - |
| Current Ratio | 2.00 | 1.79 | - |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Net Income | 135.56 | 206.23 | 20.41 | -202.66 |
| Depreciation | 78.53 | 329.59 | 297.80 | 314.45 |
| Other Funds (Non Cash) | 11.04 | 81.03 | 130.36 | 62.74 |
| Funds from Operations | 225.12 | 656.14 | 415.17 | 204.56 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -30.12 | -14.99 | -168.96 | 53.20 |
| Cash from Operating Activities | 195.00 | 641.15 | 246.21 | 257.75 |
| Capital Expenditures | -84.72 | -258.54 | -268.62 | -171.01 |
| Net Assets From Acquisitions | 0.00 | 0.00 | -0.50 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 2.82 | 244.15 | 0.00 |
| Purchase or Sale of Investments | -4.65 | 2.63 | 93.11 | 4.26 |
| Purchase of Investments | -36.42 | -63.24 | -118.97 | -85.98 |
| Sale Or Maturity of Investments | 31.77 | 65.87 | 212.08 | 90.25 |
| Other Uses | 0.00 | -9.75 | -26.81 | -0.94 |
| Other Sources | 3.47 | 12.87 | 6.63 | 24.72 |
| Cash from Investing Activities | -85.90 | -249.97 | 47.97 | -142.97 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | - | 0.00 |
| Change in Capital Stock | -0.07 | -525.09 | 933.58 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | -525.09 | -1.01 | 0.00 |
| Sale of Common Pref Stock | -0.07 | 0.00 | 934.59 | 0.00 |
| Proceedsfrom Stock Options | -0.07 | 0.00 | 934.59 | 0.00 |
| Issuance or Reduction of Debt, Net | -200.01 | 390.97 | -987.27 | -142.18 |
| Change in Long Term Debt | -200.01 | 390.97 | -987.27 | -142.18 |
| Issuance of Long Term Debt | 41.55 | 1,145.64 | 159.29 | 43.23 |
| Reduction of Long Term Debt | -241.57 | -754.67 | -1,146.56 | -185.40 |
| Net Financing Active Other Cash Flow | -25.26 | -1.73 | -5.55 | 0.00 |
| Other Financing Activities Uses | -25.35 | -1.73 | -5.55 | 0.00 |
| Cash from Financing Activities | -225.34 | -135.84 | -59.24 | -142.18 |
| Exchange Rate Effect | - | 0.00 | -0.49 | -0.11 |
| Net Change in Cash | -116.23 | 255.33 | 234.45 | -27.50 |
| Free Cash Flow | 110.29 | 382.60 | -22.41 | 86.74 |
| Deferred Taxes & Investment Tax Credit | - | 39.29 | -33.39 | 30.03 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 383.46 | 496.76 | 500.49 | - | - | - |
| Short Term Receivables | 1,249.29 | 1,166.37 | 1,159.66 | - | - | - |
| Inventories | 128.88 | 127.82 | 123.77 | - | - | - |
| Other Current Assets | 254.69 | 232.03 | 210.91 | - | - | - |
| Total Current Assets | 2,016.32 | 2,022.98 | 1,994.83 | - | - | - |
| Net Property, Plant & Equipment | 1,764.11 | 1,711.51 | 1,660.64 | - | - | - |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | - | - | - |
| Intangible Assets | 3,336.42 | 3,352.49 | 3,368.66 | - | - | - |
| Other Assets | 403.50 | 342.27 | 316.51 | - | - | - |
| Total Assets | 7,520.35 | 7,429.26 | 7,340.64 | - | - | - |
| Short Term Debt Incl. Current Port. of LT Debt | 240.24 | 230.90 | 222.37 | - | - | - |
| Accounts Payable | 66.26 | 64.05 | 65.82 | - | - | - |
| Other Current Liabilities | 849.13 | 710.89 | 779.78 | - | - | - |
| Total Current Liabilities | 1,155.64 | 1,005.85 | 1,067.98 | - | - | - |
| Long Term Debt | 4,363.63 | 4,524.06 | 5,147.93 | - | - | - |
| Provision for Risks Charges | 362.66 | 332.84 | 310.62 | - | - | - |
| Deferred Tax Liabilities | 208.74 | 209.13 | 208.95 | - | - | - |
| Other Liabilities | 521.41 | 568.12 | 100.03 | - | - | - |
| Total Liabilities | 6,612.08 | 6,639.99 | 6,835.50 | - | - | - |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | - | - | - |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 292.47 | - | - | - |
| Common Equity | 908.27 | 789.26 | 212.67 | - | - | - |
| Total Shareholders Equity | 908.27 | 789.26 | 505.14 | - | - | - |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | - | - | - |
| Total Equity | 908.27 | 789.26 | 505.14 | - | - | - |
| Total Liabilities & Stockholders Equity | 7,520.35 | 7,429.26 | 7,340.64 | - | - | - |
| Book Value Per Share | 13.62 | 14.61 | 0.95 | - | - | - |
| Tangible Book Value Per Share | -36.40 | -47.45 | -14.14 | - | - | - |
| Full-Time Employees | - | 34,000 | 34,000 | - | - | - |
| Price to Book Ratio | 0.86 | 16.22 | 15.45 | - | - | - |
| Return on Invested Capital | 2.57 | -0.53 | 1.88 | - | - | - |
| Quick Ratio | 1.63 | 1.88 | 1.75 | - | - | - |
| Current Ratio | 1.74 | 2.01 | 1.87 | - | - | - |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Net Income | 135.56 | -28.28 | 106.34 | 74.60 | 80.76 | 38.02 |
| Depreciation | 78.53 | 76.96 | 75.37 | 73.37 | 72.51 | 75.13 |
| Other Funds (Non Cash) | 11.04 | 134.98 | -2.76 | 23.83 | 26.84 | 30.17 |
| Funds from Operations | 225.12 | 183.65 | 178.94 | 171.79 | 180.11 | 143.32 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -30.12 | -95.07 | -50.19 | -27.30 | -150.78 | 46.02 |
| Cash from Operating Activities | 195.00 | 88.58 | 128.74 | 144.50 | 29.33 | 189.34 |
| Capital Expenditures | -84.72 | -73.85 | -64.14 | -65.85 | -59.14 | -52.46 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | -3.60 | 6.42 |
| Purchase or Sale of Investments | -4.65 | -2.74 | -1.72 | 1.70 | 1.83 | 1.97 |
| Purchase of Investments | -36.42 | -38.60 | -26.54 | -10.95 | -11.27 | -10.88 |
| Sale Or Maturity of Investments | 31.77 | 35.86 | 24.82 | 12.65 | 13.10 | 12.85 |
| Other Uses | 0.00 | 0.00 | 0.00 | -1.04 | 1.27 | -4.61 |
| Other Sources | 3.47 | 1.60 | 14.40 | 1.13 | 0.37 | 0.27 |
| Cash from Investing Activities | -85.90 | -74.99 | -51.46 | -64.06 | -59.28 | -48.42 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | - | 0.00 | 0.00 |
| Change in Capital Stock | -0.07 | 647.57 | -249.99 | -525.50 | -0.09 | 0.50 |
| Repurchase of Common Pref Stock | 0.00 | -299.41 | -249.99 | -525.00 | -0.09 | 0.00 |
| Sale of Common Pref Stock | -0.07 | 946.98 | 0.00 | -0.50 | 0.00 | 0.50 |
| Proceedsfrom Stock Options | -0.07 | 446.98 | 0.00 | -0.50 | 0.00 | 0.50 |
| Issuance or Reduction of Debt, Net | -200.01 | -668.89 | -14.83 | 401.24 | 23.03 | -29.58 |
| Change in Long Term Debt | -200.01 | -668.89 | -14.83 | 401.24 | 23.03 | -29.58 |
| Issuance of Long Term Debt | 41.55 | 45.36 | 27.68 | 1,022.13 | 67.03 | 10.00 |
| Reduction of Long Term Debt | -241.57 | -714.25 | -42.51 | -620.90 | -44.00 | -39.58 |
| Net Financing Active Other Cash Flow | -25.26 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 |
| Other Financing Activities Uses | -25.35 | 0.00 | 0.00 | -0.29 | 0.00 | 0.00 |
| Cash from Financing Activities | -225.34 | -21.32 | -264.82 | -123.77 | 22.95 | -29.08 |
| Net Change in Cash | -116.23 | -7.73 | -187.53 | -43.33 | -7.00 | 111.85 |
| Free Cash Flow | 110.29 | 14.73 | 64.61 | 78.65 | -29.81 | 136.88 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 13.38% | 4.7M | 35.3M | 875.96K |
| 2026-10-15 | 12.74% | 4.5M | 35.3M | 842.51K |
| 2026-09-30 | 11.53% | 4.1M | 35.3M | 797.38K |
| 2026-09-15 | 7.17% | 2.5M | 35.3M | 726.43K |
| 2026-08-31 | 9.82% | 3.2M | 33.0M | 735.43K |
| 2026-08-14 | 7.46% | 2.5M | 33.0M | 831.19K |
| 2026-07-31 | 4.10% | 1.3M | 33.0M | 1.04M |
| 2026-07-15 | 2.95% | 1.0M | 33.0M | 1.25M |
| 2026-06-30 | 4.74% | 1.6M | 33.0M | 1.40M |
| 2026-06-15 | 9.97% | 0.7M | 7.3M | 1.51M |
| 2026-05-29 | 4.64% | 0.9M | 18.7M | 2.22M |
| 2026-05-15 | 0.63% | 0.4M | 71.6M | 5.23M |
Option chain
expiry 2026-11-12| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-10 | SCHEDULE 13G/A | SEC | ||
| 2026-11-09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-09 | 8-K | Current report | 2026-11-09 | SEC |
| 2026-11-05 | SCHEDULE 13G/A | SEC | ||
| 2026-09-17 | 8-K | Current report | 2026-09-17 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-11 | 8-K | Current report | 2026-09-11 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-20 | SCHEDULE 13G | SEC | ||
| 2026-08-14 | SCHEDULE 13G | SEC | ||
| 2026-08-13 | SCHEDULE 13G | SEC | ||
| 2026-08-12 | SCHEDULE 13G | SEC | ||
| 2026-08-12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-12 | 8-K | Current report | 2026-08-12 | SEC |
| 2026-08-06 | SCHEDULE 13G | SEC | ||
| 2026-07-08 | 8-K/A | 2026-05-12 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 28.71M | 6 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 15.00K | 1 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 27.37% |
| CITADEL ADVISORS LLC | 5.90% |
| Invesco Ltd. | 5.72% |
| NORGES BANK | 5.46% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 4.44% |
| Alyeska Investment Group, L.P. | 4.41% |
| Koch, Inc. | 4.08% |
| FMR LLC | 3.38% |
| Alberta Investment Management Corp | 2.81% |
| BlackRock, Inc. | 2.32% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Fund | 3.37% |
| Invesco Discovery Fund | 2.56% |
| Invesco Small Cap Equity Fund | 1.54% |
| Putnam Core Equity Fund | 1.10% |
| MIG Core ETF | 1.06% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.66% |
| Fidelity Advisor Health Care Fund | 0.52% |
| Select Health Care Portfolio | 0.45% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.38% |
| VIP Health Care Portfolio | 0.30% |
OakChart. GMRS. Cached 15 minutes. Terms
Some panels did not load: news.